AAAAAA
Results:
1-21
|
Results: 21
Authors:
Zhang, ZM
Andersen, A
Grondin, R
Barber, T
Avison, R
Gerhardt, G
Gash, D
Citation: Zm. Zhang et al., Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys, NEUROIMAGE, 14(5), 2001, pp. 1159-1167
Authors:
Calon, F
Lavertu, N
Lemieux, AM
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bedard, PJ
Di Paolo, T
Citation: F. Calon et al., Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: Correlation with dopamine concentrations and dopamine transporter, SYNAPSE, 40(3), 2001, pp. 225-234
Authors:
Kamwa, I
Grondin, R
Loud, L
Citation: I. Kamwa et al., Time-varying contingency screening for dynamic security assessment using intelligent-systems techniques, IEEE POW SY, 16(3), 2001, pp. 526-536
Authors:
Kamwa, I
Grondin, R
Hebert, Y
Citation: I. Kamwa et al., Wide-area measurement based stabilizing control of large power systems - Adecentralized/hierarchical approach, IEEE POW SY, 16(1), 2001, pp. 136-153
Authors:
Grondin, R
Zhang, ZM
Elsberry, DD
Gerhardt, GA
Gash, DM
Citation: R. Grondin et al., Chronic intracerebral delivery of trophic factors via a programmable pump as a treatment for Parkinsonism, METH MOL M, 62, 2001, pp. 257-267
Authors:
Zhang, ZM
Andersen, A
Smith, C
Grondin, R
Gerhardt, G
Gash, D
Citation: Zm. Zhang et al., Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging, J GERONT A, 55(10), 2000, pp. B473-B480
Authors:
Grondin, R
Zang, ZM
Gerhardt, GA
Gash, DM
Citation: R. Grondin et al., Dopaminergic therapy improves upper limb motor performance in aged rhesus monkeys, ANN NEUROL, 48(2), 2000, pp. 250-253
Authors:
Calon, F
Grondin, R
Morissette, M
Goulet, M
Blanchet, PJ
Di Paolo, T
Bedard, PJ
Citation: F. Calon et al., Molecular basis of levodopa-induced dyskinesias, ANN NEUROL, 47(4), 2000, pp. S70-S78
Authors:
Goulet, M
Grondin, R
Morissette, M
Maltais, S
Falardeau, P
Bedard, PJ
Di Paolo, T
Citation: M. Goulet et al., Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys, PROG NEUR-P, 24(4), 2000, pp. 607-617
Authors:
Calon, F
Tahar, AH
Blanchet, PJ
Morissette, M
Grondin, R
Goulet, M
Doucet, JP
Robertson, GS
Nestler, E
Di Paolo, T
Bedard, P
Citation: F. Calon et al., Dopamine-receptor stimulation: biobehavioral and biochemical consequences, TRENDS NEUR, 23(10), 2000, pp. S92-S100
Authors:
Grondin, R
Tahar, AH
Doan, VD
Ladure, P
Bedard, PJ
Citation: R. Grondin et al., Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys, N-S ARCH PH, 361(2), 2000, pp. 181-186
Authors:
Calon, F
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bedard, PJ
Di Paolo, T
Citation: F. Calon et al., I-125-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: Effect of MPTP and dopaminomimetic treatments, EXP NEUROL, 163(1), 2000, pp. 191-199
Authors:
Goulet, M
Morissette, M
Grondin, R
Falardeau, P
Bedard, PJ
Rostene, W
Di Paolo, T
Citation: M. Goulet et al., Neurotensin receptors and dopamine transporters: Effects of MPTP lesioningand chronic dopaminergic treatments in monkeys, SYNAPSE, 32(3), 1999, pp. 153-164
Authors:
Kamwa, I
Grondin, R
Asber, D
Gingras, JP
Trudel, G
Citation: I. Kamwa et al., Large-scale active-load modulation for angle stability improvement, IEEE POW SY, 14(2), 1999, pp. 582-590
Authors:
Bedard, PJ
Blanchet, PJ
Levesque, D
Soghomonian, JJ
Grondin, R
Morissette, M
Goulet, M
Calon, F
Falardeau, P
Gomez-Mancilla, B
Doucet, JP
Robertson, GS
DiPaolo, T
Citation: Pj. Bedard et al., Pathophysiology of L-dopa-induced dyskinesias, MOVEMENT D, 14, 1999, pp. 4-8
Authors:
Doan, VD
Grondin, R
Tahar, AH
Gregoire, L
Bedard, PJ
Citation: Vd. Doan et al., Effect of the selective D-1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys, CLIN NEUROP, 22(5), 1999, pp. 281-287
Authors:
Calon, F
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bedard, PJ
Di Paolo, T
Citation: F. Calon et al., Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content, NEUROCHEM I, 35(1), 1999, pp. 81-91
Authors:
Grondin, R
Bedard, PJ
Tahar, AH
Gregoire, L
Mori, A
Kase, H
Citation: R. Grondin et al., Antiparkinsonian effect of a new selective adenosine A(2A) receptor antagonist in MPTP-treated monkeys, NEUROLOGY, 52(8), 1999, pp. 1673-1677
Authors:
Grondin, R
Doan, VD
Gregoire, L
Bedard, PJ
Citation: R. Grondin et al., D-1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys, NEUROLOGY, 52(4), 1999, pp. 771-776
Authors:
Morissette, M
Grondin, R
Goulet, M
Bedard, PJ
Di Paolo, T
Citation: M. Morissette et al., Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D-1 or D-2 receptor agonists, J NEUROCHEM, 72(2), 1999, pp. 682-692
Authors:
Grondin, R
Goulet, M
Morissette, M
Bedard, PJ
Di Paolo, T
Citation: R. Grondin et al., Dopamine D-1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958, EUR J PHARM, 378(3), 1999, pp. 259-263
Risultati:
1-21
|